(Q41228796)

28 September 2017

title

Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults (English)

1 reference

28 September 2017

9

John P DeVincenzo

1 reference

28 September 2017

Bindiya Bagga

1

1 reference

28 September 2017

Jeffrey E Cehelsky

2

1 reference

28 September 2017

Akshay Vaishnaw

3

1 reference

28 September 2017

Tom Wilkinson

4

1 reference

28 September 2017

Rachel Meyers

5

1 reference

28 September 2017

Lisa M Harrison

6

1 reference

28 September 2017

Philippa L Roddam

7

1 reference

28 September 2017

Edward E Walsh

8

1 reference

28 September 2017

language of work or name

English

0 references

publication date

14 May 2015

1 reference

Journal of Infectious Diseases

28 September 2017

published in

1 reference

28 September 2017

volume

212

1 reference

28 September 2017

issue

11

1 reference

28 September 2017

page(s)

1719-1725

1 reference

Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Natural infection of infants with respiratory syncytial virus subgroups A and B: a study of frequency, disease severity, and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Serum antibody decay in adults following natural respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Adjuvanted influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Localized mucosal response to intranasal live attenuated influenza vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Experimental infection of humans with A2 respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Vaccines: correlates of vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV281

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV281

1 reference

28 September 2017

1 reference